Renal function and blood pressure are tightly linked and hypertension per se is a risk factor for the development of end-stage renal disease (ESRD) 1, 2) . The renin-angioten -sin-aldosterone system (RAAS) is a key regulator of both blood pressure and renal function, so that genes encoding components of the RAAS can be candidate genes for evalu- Received October 26, 2009. Revised November 23, 2009. Accepted November 23, 2009 Corresponding author: Young Joo Kwon, M.D. Korea University Guro Hospital, 97 Gurodong-Gil, Guro-Gu, Seoul, 152-703, Korea Tel: +82-2-2626-3036, Fax: +82-2-2626-1077 E-mail: yjkwon@korea.ac.kr ating predisposition for the development of hypertension, cardiovascular disease and progression of renal disease. . The CYP11B2 -344C/T polymorphism, which is located at a putative binding site for the steroidogenic transcription factor (SF-1), has been Aldosterone synthase gene (CYP11B2) -344C/T polymorphism has been reported to be associated with serum aldosterone level, urinary aldosterone excretion, blood pressure, and left ventricular size and mass.
ating predisposition for the development of hypertension, cardiovascular disease and progression of renal disease.
Polymorphisms have been described in the genes encoding several important components of the RAAS, including angiotensinogen 3) , angiotensin-converting enzyme 4) , angiotensin type receptors І 5) , and aldosterone synthase 6) .
The aldosterone synthase gene, CYP11B2, encodes for a cytochrome P450 enzyme, involved in the terminal steps of aldosterone synthesis in the zona glomerulosa cells of human adrenal glands and its expression is regulated by angiotensin II and potassium 7) . The CYP11B2 -344C/T polymorphism, which is located at a putative binding site for the steroidogenic transcription factor (SF-1), has been
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reported to be associated with serum aldosterone level 8) , urinary aldosterone excretion 9) , blood pressure [9] [10] [11] [12] , left ventricular size and mass 13, 14) . However, there were few studies on the association of CYP11B2 -344C/T polymorphism and renal function, which has inconsistent results 15, 16) . The aim of this study is to evaluate the relation between CYP11B2 polymorphism and ESRD in the Korean population and the association with CYP11B2 polymorphism and cardiovascular morbidity in ESRD patients on hemodialysis.
Methods

Subjects
The study subjects were 271 ESRD patients on maintenance hemodialysis over three months from dialysis cen- 
Genotyping
Genomic DNA was extracted from peripheral blood using the DNA extraction kit (G-Dex 
Statistical analysis
Statistical analysis was performed using the Statistical 
Results
The baseline characteristics of controls and ESRD patients are summarized in Table 1 . The mean age and male prevalence were similar between controls and ESRD patients. Genotype and allele frequencies for the polymorphism of CYP11B2 in controls and ESRD patients are presented in Table 2 . The controls and ESRD patients were in Hardy-Weinberg equilibrium for the polymorphism.
Genotype distribution of CYP11B2 polymorphism did not differ between controls and ESRD patients. However, these findings were not significant after adjustment for age and sex. In addition, there was no association of CYP11B2 polymorphism with left ventricular hypertrophy or cardiovascular disease in ESRD patients (Table   4 ).
Discussion
Our study was designed to test the hypothesis that the prevalence of renal failure may be influenced by gene polymorphism of the RAAS, especially aldosterone synthase gene polymorphism. In this cross-sectional study, we could not observe significant differences in the genotype and allele frequency of the CYP11B2 -344C/T polymorphism between controls and ESRD patients. Previous studies performed in Europe showed inconsistent results. Lovati et . On the other hand, Fabris et al. report ed that significant association was found between the CYP11B2 gene polymorphism and renal insufficiency in the hypertensive population 16) . They observed an increased . In the Korean population, there has been research aimed at evaluating the association between CYP11B2 polymorphism and hypertension 18) , myocardial infarction 19) , and risk of coronary in-stent restenosis 20) . To our knowledge, this is the first report about the CYP11B2 C-344T allele frequency in Korean ESRD patients.
Several studies of the association between this polymorphism and hypertension 12, 21, 22) , left ventricle size and mass 13, 23) , arterial stiffness 24) , and myocardial infarction 14, 25) in the general population and hypertensive individuals with normal renal function have been performed. In ESRD patients, however, studies of association of CYP11B2 -344C/T polymorphism and left ventricular hypertrophy and cardiovascular morbidity are few. Our results did not show significant differences in left ventricular hypertrophy by EKG criteria and cardiovascular disease among the three genotypes in ESRD patients. We think this lack of association is due to not only limitation of the study, but 
